ADA and type 1 diabetes mellitus: Despite earlier evidence indicating a high prevalence of thyroid autoimmunity in individuals with type 1 diabetes (13, 24), screening was performed at irregular intervals, reflecting the lack of specific ADA recommendations in the late 1980s and early 1990s.